Delia Carias, PharmD, BCPS, dPLA, FASHP

Delia Carias, PharmD, BCPS, dPLA, FASHP

  • Medication-Use Safety and Policy Residency Coordinator

Board Certifications

  • BCPS
  • Diplomate, Pharmacy Leadership Academy

Education

  • BA Music - University of Alabama at Birmingham, Birmingham, Alabama
  • PharmD - McWhorter School of Pharmacy Samford University, Birmingham, Alabama

Post-Graduate Training

  • PGY1 Pharmacy Practice Residency – The Johns Hopkins Hospital, Baltimore, Maryland
  • PGY2 Health System Pharmacy Administration Residency – Methodist Le Bonheur Healthcare, Memphis, Tennessee

Focused Area of Practice

  • Medication Use Policy/Formulary Management

Honors/Awards

  • 2023 St. Jude Children’s Research Hospital Values Award
  • 2020  St. Jude Children’s Research Hospital 5100 Club Award Winner
  • 2016  St. Jude Children's Research Hospital Clinical Care Improvement Award for Antimicrobial Stewardship Program

Research Interests

  • Adverse Drug Reactions
  • Formulary Management
  • Performance Improvement
  • Change management
  • Productivity and time management

St Jude Committee Service

  • Pharmacy and Therapeutics Committee – Vice Chair
  • Women’s and Allies Resouce Group – Data Coordinator
  • Antimicrobial Utilization and Improvement Committee
  • Infection Control and Prevention
  • Medication Use Safety Team
  • Clinical Knowledge Management Committee
  • Residency Advisory Committee

Pharmacy Organizations/Committee Service

  • American Society of Health-System Pharmacists (ASHP)
  • American College of Clinical Pharmacy (ACCP)
  • Tennessee Pharmacy Association
  • Tennessee Society of Health-System Pharmacists

Related Topics

Selected Publications

Carias DC, Daniels CC, Robertson J. All pharmacists provide patient care. American Journal of Health-System Pharmacy. 2023;80(14):876. doi:10.1093/ajhp/zxac359

Sitthi-Amorn J, Denton E, Harper E, Carias D, et al. Improving Blood Product Transfusion Premedication Plan Documentation: A Single-institution Quality Improvement Effort. Pediatr Qual Saf. 2022;7(3):e572. Published 2022 Jun 14. doi:10.1097/pq9.0000000000000572  

Gilliam CH, Brazelton de Cardenas J, Carias D, Maron Alfaro G, Hayden RT, Hakim H. Lactobacillus bloodstream infections genetically related to probiotic use in pediatric hematopoietic cell transplant patients [published online ahead of print, 2022 Feb 28]. Infect Control Hosp Epidemiol. 2022;1-4. doi:10.1017/ice.2021.515

Lee L, Carias DC, Gosser R, Hannah A, Stephens S, Templeman W. ASHP Guidelines on Adverse Drug Reaction Monitoring and Reporting. American Journal of Health-System Pharmacy. 2021; zxab324.

Lambrix A, Swanson H, Pauley J, Bragg A, Carias D, Maron G, Bourque M, Zhou Y, Greene W. Experience using intravenous posaconazole in pediatric and young adult oncology patients. J Antimicrob Chemother. Dec;75(12):3682-3687, 2020.

Quinn M, Fannin JT, Sciasci J, Bragg A, Campbell PK, Carias D, et al. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy. Antimicrob Agents Chemother. July;62(8). 2018.

Carias DC. Sometimes others know you better than you know yourself. In: Cantrell SA, White SJ, eds. Letters from rising pharmacy stars: advice on creating and advancing your career in a changing profession.  Bethesda, MD: American Society of Health-System Pharmacist; 2017.

Wolf J, Sun Y, Li Tang, Newland J, Gerber J, Van Dyke C, Hymes S, Yu D, Carias D,Bryant P. Antimicrobial Stewardship Barriers and Goals in Pediatric Oncology and Bone Marrow Transplantation: A Survey of Antimicrobial Stewardship Practitioners. Infection Control & Hospital Epidemiology. Available on CJO 2015 doi:10.1017/ice.2015.295

Charest DM, Krogsgard ES, Thomason AR. A patient case: intravenous azithromycin-induced hepatotoxicity. Hosp Pharm July;45(7):545-548, 2010.

Last update: September 2023

Close
Close